The agenda for the 9 July 2014 Transparency Commission meeting is now available. The Commission will consider the following health care technologies:

• Innohep (tinzaparin sodium) - new indication
• Macitentan (Opsumit) - review of SMR
• Riociguat (Adempas) - review of SMR
• Sinecatechins (Veregen) - review of SMR

For more details, go to: http://www.has-sante.fr/portail/upload/docs/application/pdf/2014-07/odj_ct_09072014_internet.pdf